Amorsa Therapeutics, Inc.
www.amorsatx.comAmorsa is pioneering the development of novel (patented) ketamine analogs for treating neuropsychiatric disorders including treatment resistant depression, PTSD and obsessive-compulsive disorder.
Read moreAmorsa is pioneering the development of novel (patented) ketamine analogs for treating neuropsychiatric disorders including treatment resistant depression, PTSD and obsessive-compulsive disorder.
Read moreCountry
Industry
Employees
1-10
Founded
2013
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(16)
Reach decision makers at Amorsa Therapeutics, Inc.
Free credits every month!
Amorsa Therapeutics, Inc. FAQ
United States
Pharmaceutical Manufacturing